As GLP-1 adoption grows and new applications for the drugs come to light, experts say that could have sweeping impacts for ...

The announcement quickly drew attention from actress and activist Jameela Jamil, who took to Instagram to caution fans about ...

The increase in costs could make affording medicine and health care even more expensive for people with lower incomes.

With millions of Americans prescribed GLP-1 drugs, researchers warn of catastrophic risks ignored by Big Pharma.

The latest results from a trial of a pill form popular GLP-1 medications offer enough information for the Eli Lilly to ...

Drugmaker Eli Lilly says its daily oral GLP-1 pill may help people who have obesity and people with Type 2 diabetes lose ...

New data from Eli Lilly says its daily, oral GLP-1 pill may help people who have obesity and people who have Type 2 diabetes lose a significant amount of weight.

For individuals with type 2 diabetes (T2D), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with a slightly increased risk for incident diabetic retinopathy (DR) and with a ...

Findings also show improved persistence with high-potency, obesity-approved GLP-1 products Eagan, Minn. – June 25, 2025 – Only 8% of individuals (or 1 in 12) initiating a glucagon-like peptide-1 ...

The small study followed patients for six months and found that 54 percent experienced a reduction in their symptoms after taking a GLP-1RA. Most of the patients had type 2 diabetes and the median BMI ...